Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Shares Outstanding (2023 - 2025)

Historic Shares Outstanding for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q3 2025 value amounting to $34.1 million.

  • SeaStar Medical Holding's Shares Outstanding rose 70904.58% to $34.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.1 million, marking a year-over-year increase of 70904.58%. This contributed to the annual value of $6.0 million for FY2024, which is 19647.89% up from last year.
  • According to the latest figures from Q3 2025, SeaStar Medical Holding's Shares Outstanding is $34.1 million, which was up 70904.58% from $17.3 million recorded in Q2 2025.
  • Over the past 5 years, SeaStar Medical Holding's Shares Outstanding peaked at $34.1 million during Q3 2025, and registered a low of $531861.0 during Q1 2023.
  • Over the past 3 years, SeaStar Medical Holding's median Shares Outstanding value was $3.2 million (recorded in 2024), while the average stood at $7.4 million.
  • Over the last 5 years, SeaStar Medical Holding's Shares Outstanding had its largest YoY gain of 70904.58% in 2025, and its largest YoY loss of 19594.1% in 2025.
  • Quarter analysis of 3 years shows SeaStar Medical Holding's Shares Outstanding stood at $2.0 million in 2023, then surged by 196.48% to $6.0 million in 2024, then skyrocketed by 470.44% to $34.1 million in 2025.
  • Its Shares Outstanding stands at $34.1 million for Q3 2025, versus $17.3 million for Q2 2025 and $9.3 million for Q1 2025.